Heartbeam Stock Analysis

Heartbeam Stock Analysis Notes

About 29.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Heartbeam recorded a loss per share of 0.68. The entity had not issued any dividends in recent years. HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. For more info on Heartbeam please contact the company at 408 899 4443 or go to https://www.heartbeam.com.

Heartbeam Investment Alerts

Heartbeam Upcoming and Recent Events

Heartbeam Largest EPS Surprises

View All Earnings Estimates

Heartbeam Environmental, Social, and Governance (ESG) Scores

Heartbeam Stock Institutional Investors

Note, although Heartbeam's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Heartbeam Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 75.46 M.

Heartbeam Profitablity

Management Efficiency

Heartbeam has return on total asset (ROA) of (0.6975) % which means that it has lost $0.6975 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1362) %, meaning that it created substantial loss on money invested by shareholders. Heartbeam's management efficiency ratios could be used to measure how well Heartbeam manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.9 in 2024. Return On Capital Employed is likely to gain to -0.91 in 2024. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 16.3 M in 2024.

Technical Drivers

As of the 26th of November, Heartbeam retains the market risk adjusted performance of 0.3362, and Risk Adjusted Performance of 0.072. Heartbeam technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Heartbeam Price Movement Analysis

Heartbeam Insider Trading Activities

Heartbeam Outstanding Bonds

Heartbeam Predictive Daily Indicators

Heartbeam Corporate Filings

Heartbeam Forecast Models

Heartbeam's time-series forecasting models are one of many Heartbeam's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heartbeam's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Heartbeam prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heartbeam shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heartbeam. By using and applying Heartbeam Stock analysis, traders can create a robust methodology for identifying Heartbeam entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heartbeam analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heartbeam analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Heartbeam stock analysis indicators help investors evaluate how Heartbeam stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Heartbeam shares will generate the highest return on investment. By understating and applying Heartbeam stock analysis, traders can identify Heartbeam position entry and exit signals to maximize returns.

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.